TrueBlue, Inc. (NYSE:TBI) EVP Carl Schweihs sold 4,000 shares of the company’s stock in a transaction dated Thursday, April 29th. The stock was sold at an average price of $28.07, for a total value of $112,280.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Carl Schweihs also recently made the following trade(s):
- On Wednesday, February 24th, Carl Schweihs sold 5,502 shares of TrueBlue stock. The stock was sold at an average price of $21.40, for a total value of $117,742.80.
TBI stock traded up $0.94 during mid-day trading on Monday, reaching $29.24. 205,387 shares of the company’s stock were exchanged, compared to its average volume of 215,328. The company has a market cap of $1.04 billion, a price-to-earnings ratio of -7.72 and a beta of 1.70. The stock’s 50 day moving average is $23.03 and its 200 day moving average is $20.14. TrueBlue, Inc. has a 12-month low of $12.30 and a 12-month high of $29.90.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Veriti Management LLC purchased a new position in shares of TrueBlue in the fourth quarter valued at approximately $60,000. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of TrueBlue by 36.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,021 shares of the business services provider’s stock valued at $150,000 after purchasing an additional 2,151 shares during the last quarter. Robeco Institutional Asset Management B.V. increased its holdings in shares of TrueBlue by 250.2% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 8,986 shares of the business services provider’s stock valued at $168,000 after purchasing an additional 6,420 shares during the last quarter. Crossmark Global Holdings Inc. acquired a new stake in shares of TrueBlue in the first quarter valued at approximately $203,000. Finally, First Hawaiian Bank acquired a new stake in shares of TrueBlue in the fourth quarter valued at approximately $238,000. Institutional investors and hedge funds own 90.69% of the company’s stock.
TBI has been the topic of a number of recent research reports. Robert W. Baird upgraded TrueBlue from a “neutral” rating to an “outperform” rating and upped their target price for the stock from $21.00 to $29.00 in a research note on Monday. Zacks Investment Research upgraded TrueBlue from a “hold” rating to a “strong-buy” rating and set a $33.00 target price on the stock in a research note on Friday. Finally, Credit Suisse Group upped their target price on TrueBlue from $19.00 to $23.00 and gave the stock a “neutral” rating in a research note on Monday. Three investment analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $25.00.
TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The PeopleReady segment offers a range of contingent staffing solutions for blue-collar, on-demand, and skilled labor in construction, manufacturing and logistics, warehousing and distribution, waste and recycling, energy, retail, hospitality, general labor, and other industries.
Featured Article: How to interpret Moving Average Convergence Divergence (MACD)
Receive News & Ratings for TrueBlue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueBlue and related companies with MarketBeat.com's FREE daily email newsletter.